This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Ottawa directory, so their courses may be missing. Find their university profile.
Research
Read how they describe their research on their University of Ottawa profile.
Latest papers
Real-world management and clinical outcomes of first line treatment of advanced renal cell carcinoma in older patients in Canada
Journal of Geriatric Oncology · 2026
Real-world assessment of clinical outcomes of first-line treatment in metastatic papillary renal cell carcinoma
Oncologist · 2025
Impact of Timing of Immunotherapy and Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma: Real-World Data on Survival Outcomes from the CKCis Database
Current Oncology · 2024
Latest funding
- $100,000
The Impact of language on care and outcomes in patients with prostate or breast cancer
CIHR · 2024 · Co-investigator
- $810,900
Active Cancer Patients Having Cancer-Related Invasive Procedures or Surgery and Needing Perioperative Management of Anticoagulation Therapy (ACE-HIGH) - A Prospective Management Cohort Study
CIHR · 2024 · Co-investigator
- $164,476
EPIphANy (Evaluation of Pharmacological Interactions with Anticoagulants in caNcer patients) program - prostate cancer cohort
CIHR · 2023 · Co-investigator
10 publications.
Real-world management and clinical outcomes of first line treatment of advanced renal cell carcinoma in older patients in Canada
Curry L, Ghosh S, Arenovich E, Tanguay S, Lalani A-KA, Heng DYC, Bhindi B, Basappa NS, Graham J, Bjarnason GA
Real-world assessment of clinical outcomes of first-line treatment in metastatic papillary renal cell carcinoma
De Vries-Brilland M, Hamilou Z, Ghosh S, Heng DYC, Wood LA, Basappa NS, Kollmannsberger CK, Graham J, Bhindi B, Finelli A
Impact of Timing of Immunotherapy and Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma: Real-World Data on Survival Outcomes from the CKCis Database
Park CL, Moria FA, Ghosh S, Wood L, Bjarnason GA, Bhindi B, Heng DYC, Castonguay V, Pouliot F, Kollmannsberger CK
Association of Cabozantinib Dose Reductions for Toxicity With Clinical Effectiveness in Metastatic Renal Cell Carcinoma (mRCC): Results From the Canadian Kidney Cancer Information System (CKCis).
Graham J, Ghosh S, Breau RH, Wood L, Tanguay S, Bosse D, Lalani AK, Bhindi B, Heng D, Finelli A, Fallah-Rad N, Castonguay V, Basappa NS, Soulières D, Pouliot F, Kollmannsberger C, Bjarnason GA
Population Survival Kinetics Derived from Clinical Trials of Potentially Curable Lung Cancers.
Stewart DJ, Cole K, Bosse D, Brule S, Fergusson D, Ramsay T
Adjuvant therapy for renal cell carcinoma: 2023 Canadian Kidney Cancer Forum consensus statement
Lalani A-KA, Kapoor A, Basappa NS, Bhindi B, Bjarnason GA, Bosse D, Breau RH, Canil CM, Cardenas LM, Castonguay V
Outcomes of Second-Line Therapies in Patients With Metastatic de Novo and Treatment-Emergent Neuroendocrine Prostate Cancer: A Multi-Institutional Study.
Eule CJ, Hu J, Al-Saad S, Collier K, Boland P, Lewis AR, McKay RR, Narayan V, Bosse D, Mortazavi A, Rose TL, Costello BA, Bryce AH, Lam ET
A population-based study of factors associated with systemic treatment in advanced prostate cancer decedents.
Leigh J, Qureshi D, Sucha E, Mahdavi R, Kushnir I, Lavallée LT, Bosse D, Webber C, Tanuseputro P, Ong M
Adverse Events Associated with Immune Checkpoint Inhibitors: Overview of Systematic Reviews.
Kanji S, Morin S, Agtarap K, Purkayastha D, Thabet P, Bosse D, Wang X, Lunny C, Hutton B
Cabozantinib in advanced non-clear-cell renal cell carcinoma: a multicentre, retrospective, cohort study.
Martínez Chanzá N, Xie W, Asim Bilen M, Dzimitrowicz H, Burkart J, Geynisman DM, Balakrishnan A, Bowman IA, Jain R, Stadler W, Zakharia Y, Narayan V, Beuselinck B, McKay RR, Tripathi A, Pachynski R, Hahn AW, Hsu J, Shah SA, Lam ET, Rose TL, Mega AE, Vogelzang N, Harrison MR, Mortazavi A, Plimack ER, Vaishampayan U, Hammers H, George S, Haas N, Agarwal N, Pal SK, Srinivas S, Carneiro BA, Heng DYC, Bosse D, Choueiri TK, Harshman LC
The Impact of language on care and outcomes in patients with prostate or breast cancer
Principal investigators: Wang, Tzu-Fei; Tanuseputro, Peter
Keywords: Allophones; Cancer Patients; Francophones; Health Administrative Data; Language Barriers; Language Concordance; Linguistic Minorities; Oncology; Population Health
Active Cancer Patients Having Cancer-Related Invasive Procedures or Surgery and Needing Perioperative Management of Anticoagulation Therapy (ACE-HIGH) - A Prospective Management Cohort Study
Principal investigators: Shaw, Joseph; Carrier, Marc
Keywords: Anticoagulant-Associated Bleeding; Anticoagulants; Atrial Fibrillation; Cancer; Direct Oral Anticoagulants; Elective Surgery; Low-Molecular-Weight Heparin; Perioperative Medicine; Venous Thromboembolism; Warfarin
EPIphANy (Evaluation of Pharmacological Interactions with Anticoagulants in caNcer patients) program - prostate cancer cohort
Principal investigators: Wang, Tzu-Fei; Sood, Manish M
Keywords: Anticoagulation; Direct Oral Anticoagulants; Drug-To-Drug Interactions; Hemorrhage; Prostate Cancer; Thrombosis; Warfarin
PREVENT GU: Prevention of thromboembolism with rivaroxaban in GU cancer patients receiving chemotherapy: A Randomized Placebo-Controlled, Double-Blind Clinical Trial
Principal investigators: Lavallée, Luke T; Bossé, Dominick; Breau, Rodney H; Carrier, Marc
Keywords: Anticoagulants; Bladder Cancer; Bleeding; Chemotherapy; Genitourinary Malignancy; Thromboprophylaxis
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Peter Tanuseputro and Colleen Webber: 57 shared papers
- Dean Fergusson and Brian Hutton: 53 shared papers
- Aly-Khan Lalani and Antonio Finelli: 19 shared papers
- Brian Hutton and Salmaan Kanji: 19 shared papers
- Aly-Khan Lalani and Anand Swaminath: 11 shared papers
- Aly-Khan Lalani and Eric Winquist: 10 shared papers
- Aly-Khan Lalani and Michael Ong: 8 shared papers
- Dean Fergusson and Salmaan Kanji: 6 shared papers
- Antonio Finelli and Eric Winquist: 5 shared papers
- Aly-Khan Lalani and Dominick Bossé: 4 shared papers
- Brian Hutton and Michael Ong: 4 shared papers
- Antonio Finelli and Dominick Bossé: 4 shared papers
- Antonio Finelli and Michael Ong: 4 shared papers
- Eric Winquist and Michael Ong: 3 shared papers
- Anand Swaminath and Eric Winquist: 2 shared papers
- Anand Swaminath and Scott Morgan: 2 shared papers
- Dean Fergusson and Michael Ong: 2 shared papers
- Peter Tanuseputro and Michael Ong: 2 shared papers
- Michael Ong and Colleen Webber: 2 shared papers
- Aly-Khan Lalani and Scott Morgan: 1 shared paper
- Anand Swaminath and Dominick Bossé: 1 shared paper
- Dean Fergusson and Peter Tanuseputro: 1 shared paper
- Dean Fergusson and Dominick Bossé: 1 shared paper
- Dean Fergusson and Scott Morgan: 1 shared paper
- Brian Hutton and Dominick Bossé: 1 shared paper
- Peter Tanuseputro and Salmaan Kanji: 1 shared paper
- Peter Tanuseputro and Dominick Bossé: 1 shared paper
- Salmaan Kanji and Dominick Bossé: 1 shared paper
- Salmaan Kanji and Colleen Webber: 1 shared paper
- Eric Winquist and Dominick Bossé: 1 shared paper
- Dominick Bossé and Michael Ong: 1 shared paper
- Dominick Bossé and Colleen Webber: 1 shared paper
- Dominick Bossé and Scott Morgan: 1 shared paper
- Department of Medicine
- Oncology
- School of Epidemiology and Public Health
- Clinical Pharmacology
- Other
Co-authors at University of Ottawa, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
Antonio Finelli
Faculty
4 shared papers, latest 2026
Aly-Khan Lalani
Oncology
4 shared papers, latest 2026
Michael Ong
Faculty
1 shared papers, latest 2023
Colleen Webber
Faculty
1 shared papers, latest 2023
Scott Morgan
Faculty
1 shared papers, latest 2023
Dean Fergusson
Department of Medicine
1 shared papers, latest 2024
Brian Hutton
School of Epidemiology and Public Health
1 shared papers, latest 2022
Peter Tanuseputro
Department of Medicine
1 shared papers, latest 2023
Salmaan Kanji
Department of Medicine
1 shared papers, latest 2022
Eric Winquist
Clinical Pharmacology
1 shared papers, latest 2025
Anand Swaminath
Oncology
1 shared papers, latest 2023
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.